<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33926115</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4536</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22094536</ELocationID><Abstract><AbstractText>Neurological disorders, including neurodegenerative diseases, are collectively a major cause of death and disability worldwide. Whilst the underlying disease mechanisms remain elusive, altered mitochondrial function has been clearly implicated and is a key area of study in these disorders. Studying mitochondrial function in these disorders is difficult due to the inaccessibility of brain tissue, which is the key tissue affected in these diseases. To overcome this issue, numerous cell models have been used, each providing unique benefits and limitations. Here, we focussed on the use of lymphoblastoid cell lines (LCLs) to study mitochondrial function in neurological disorders. LCLs have long been used as tools for genomic analyses, but here we described their use in functional studies specifically in regard to mitochondrial function. These models have enabled characterisation of the underlying mitochondrial defect, identification of altered signalling pathways and proteins, differences in mitochondrial function between subsets of particular disorders and identification of biomarkers of the disease. The examples provided here suggest that these cells will be useful for development of diagnostic tests (which in most cases do not exist), identification of drug targets and testing of pharmacological agents, and are a worthwhile model for studying mitochondrial function in neurological disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Annesley</LastName><ForeName>Sarah Jane</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-7604-3985</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Paul Robert</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-1884-6306</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10862.01</GrantID><Agency>Michael J. Fox Foundation for Parkinson's Research</Agency><Country/></Grant><Grant><GrantID>MASONMECFS051 and MAS2018F00026</GrantID><Agency>THE JUDITH JANE MASON &amp; HAROLD STANNETT WILLIAMS MEMORIAL FOUNDATION</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C564105">Fragile X Tremor Ataxia Syndrome</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001259" MajorTopicYN="N">Ataxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="N">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005600" MajorTopicYN="N">Fragile X Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014202" MajorTopicYN="N">Tremor</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cell models</Keyword><Keyword MajorTopicYN="N">lymphoblastoid cell lines</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">neurological disorder</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33926115</ArticleId><ArticleId IdType="pmc">PMC8123577</ArticleId><ArticleId IdType="doi">10.3390/ijms22094536</ArticleId><ArticleId IdType="pii">ijms22094536</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Annesley S.J., Chen S., Francione L.M., Sanislav O., Chavan A.J., Farah C., De Piazza S.W., Storey C.L., Ilievska J., Fernando S.G., et al. Dictyostelium, a microbial model for brain disease. BBA-Gen. Subj. 2014;1840:20. doi: 10.1016/j.bbagen.2013.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2013.10.019</ArticleId><ArticleId IdType="pubmed">24161926</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce X.G., Annesley S.J., Fisher P.R. The Dictyostelium model for mitochondrial biology and disease. Int. J. Dev. Biol. 2019;63:12. doi: 10.1387/ijdb.190233pf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1387/ijdb.190233pf</ArticleId><ArticleId IdType="pubmed">31840787</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller-Fleming L., Giorfini F., Outeiro T.F. Yeast as a model for studying human neurodegenerative disorders. Biotechnol. J. 2008;3:14. doi: 10.1002/biot.200700217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biot.200700217</ArticleId><ArticleId IdType="pubmed">18228539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A., Cox R.T. Fly Models of Human Diseases: Drosophila as a Model for Understanding Human Mito-chondrial Mutations and Disease. Curr. Top. Dev. Biol. 2017;121:28.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057297</ArticleId></ArticleIdList></Reference><Reference><Citation>Teresa Rinaldi C.D., Ferrero I., Frontali L., Bolotin-Fukuhara M. Mitochondrial diseases and the role of the yeast models. FEMS Yeast Res. 2010;10:17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20946356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolus H., Crocker K., Boekhoff-Falk G., Chtarbanova S. Modeling Neurodegenerative Disorders in Drosophila melanogaster. Int. J. Mol. Sci. 2020;21:3055. doi: 10.3390/ijms21093055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21093055</ArticleId><ArticleId IdType="pmc">PMC7246467</ArticleId><ArticleId IdType="pubmed">32357532</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldwell K.A., Willicott C.W., Caldwell G.A. Modeling neurodegeneration in Caenorhabditis elegans. Dis. Models Mech. 2020 doi: 10.1242/dmm.046110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.046110</ArticleId><ArticleId IdType="pmc">PMC7648605</ArticleId><ArticleId IdType="pubmed">33106318</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang W.Y., Lemire B.D. The role of mitochondria in the life of the nematode, Caenorhabditis elegans. BBA. 2003;1638:15. doi: 10.1016/S0925-4439(03)00079-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4439(03)00079-6</ArticleId><ArticleId IdType="pubmed">12853115</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow R.H. Is aging part of Alzheimer&#x2019;s disease, or is Alzheimer&#x2019;s disease part of aging? Neurobiol. Aging. 2007;28:16. doi: 10.1016/j.neurobiolaging.2006.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2006.06.021</ArticleId><ArticleId IdType="pubmed">16876913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Kirby J., Ferraiuolo L., Heath P.R., Rattray M., Shaw P.J. Gene expression profiling in human neurodegenerative disease. Nat. Rev. Neurol. 2012;9:13.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890216</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinho R., Guedes L.C., Soreq L., Lobo P.P., Mestre T., Coelho M., Rosa M.M., Gon&#xe7;alves N., Wales P., Mendes T., et al. Gene Expression Differences in Peripheral Blood of Parkinson&#x2019;s Disease Patients with Distinct Pro-gression Profiles. PLoS ONE. 2017;12:e0157852</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913914</ArticleId><ArticleId IdType="pubmed">27322389</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreq L., Guffanti A., Salomonis N., Simchovitz A., Israel Z., Bergman H., Soreq H. Long non-coding RNA and alternative splicing modulations in Parkinson&#x2019;s leukocytes identified by RNA sequencing. PLoS Comput. Biol. 2014;10 doi: 10.1371/journal.pcbi.1003517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003517</ArticleId><ArticleId IdType="pmc">PMC3961179</ArticleId><ArticleId IdType="pubmed">24651478</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreq L., Bergman H., Goll Y., Greenberg D.S., Israel Z., Soreq H. Deep brain stimulation induces rapidly reversible transcript changes in Parkinson&#x2019;s leucocytes. J. Cell. Mol. Med. 2012;16:12. doi: 10.1111/j.1582-4934.2011.01444.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2011.01444.x</ArticleId><ArticleId IdType="pmc">PMC3823218</ArticleId><ArticleId IdType="pubmed">21910823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhao F., Ma X., Perry G., Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer&#x2019;s disease: Recent advances. Mol. Neurodegener. 2020;15 doi: 10.1186/s13024-020-00376-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00376-6</ArticleId><ArticleId IdType="pmc">PMC7257174</ArticleId><ArticleId IdType="pubmed">32471464</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.-S., Davis R.L., Sue C.M. Mitochondrial Dysfunction in Parkinson&#x2019;s Disease: New Mechanistic Insights and Therapeutic Perspectives. Curr. Neurol. Neurosci. Rep. 2018;18:1&#x2013;11. doi: 10.1007/s11910-018-0829-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-018-0829-3</ArticleId><ArticleId IdType="pmc">PMC5882770</ArticleId><ArticleId IdType="pubmed">29616350</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo C., Naia L., Lopes CRego A.C. Mitochondrial Dysfunction in Huntington&#x2019;s Disease. Adv. Exp. Med. Biol. 2018;1049:25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29427098</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohela D., Berguerand N.C., Tassone F., Singh R. The emerging molecular mechanisms for mitochondrial dysfunctions in FXTAS. BBA-Mol. Basis Dis. 2020;1866:165918. doi: 10.1016/j.bbadis.2020.165918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.165918</ArticleId><ArticleId IdType="pubmed">32800941</ArticleId></ArticleIdList></Reference><Reference><Citation>Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 1952;12:2.</Citation></Reference><Reference><Citation>Wang H., Lim P.J., Karbowski M., Monteiro M.J. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum. Mol. Genet. 2009;18:16. doi: 10.1093/hmg/ddn404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn404</ArticleId><ArticleId IdType="pmc">PMC2722218</ArticleId><ArticleId IdType="pubmed">19039036</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata A., Riley B.E., Johnston J.A., Kopito R.R. HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin. J. Biol. Chem. 2005;280:11. doi: 10.1074/jbc.M508786200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M508786200</ArticleId><ArticleId IdType="pubmed">16192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Mi Y., Mueller T., Kreibich S., Williams E.G., Van Drogen A., Borel C., Frank M., Germain P.L., Bludau I., et al. Multi-omic measurements of heterogeneity in HeLa cells across laboratories. Nat. Biotechnol. 2019;37:9. doi: 10.1038/s41587-019-0037-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0037-y</ArticleId><ArticleId IdType="pubmed">30778230</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrizi S.J., Orth M., Wilkinson J.M., Taanman J.W., Warner T.T., Cooper J.M., Schapira A.H. Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 2000;9:7. doi: 10.1093/hmg/9.18.2683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.18.2683</ArticleId><ArticleId IdType="pubmed">11063727</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X., Dzamko N., Prescott A., Davies P., Liu Q., Yang Q., Lee J.-D., Patricelli M.P., Nomanbhoy T.K., Alessi D.R., et al. Characterization of a selective inhibitor of the Parkinson&#x2019;s disease kinase LRRK2. Nat. Chem. Biol. 2011;7:3. doi: 10.1038/nchembio.538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.538</ArticleId><ArticleId IdType="pmc">PMC3287420</ArticleId><ArticleId IdType="pubmed">21378983</ArticleId></ArticleIdList></Reference><Reference><Citation>Houck A.L., Hernandez F., Avila J. A simple model to study tau pathology. J. Exp. Neurosci. 2016;10:8. doi: 10.4137/JEN.S25100.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/JEN.S25100</ArticleId><ArticleId IdType="pmc">PMC4768941</ArticleId><ArticleId IdType="pubmed">26949341</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977;36:14. doi: 10.1099/0022-1317-36-1-59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-36-1-59</ArticleId><ArticleId IdType="pubmed">886304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bylund L., Kytola S., Lui W.-O., Larsson C., Weber G. Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches. Cytogenet. Genome Res. 2004;106:5. doi: 10.1159/000078556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000078556</ArticleId><ArticleId IdType="pubmed">15218237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.-C., Boone M., Meuris L., Lemmens I., Van Roy N., Soete A., Reumers J., Moisse M., Plaisance S., Drmanac R., et al. Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations. Nat. Commun. 2014;5:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4166678</ArticleId><ArticleId IdType="pubmed">25182477</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 1978;38:7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29704</ArticleId></ArticleIdList></Reference><Reference><Citation>Xicoy H., Wieringa B., Martens G.J.M. The SH-SY5Y cell line in Parkinson&#x2019;s disease research: A systematic review. Mol. Neurodegener. 2017;12 doi: 10.1186/s13024-017-0149-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0149-0</ArticleId><ArticleId IdType="pmc">PMC5259880</ArticleId><ArticleId IdType="pubmed">28118852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari E., Cardinale A., Picconib B., Gardoni F. From cell lines to pluripotent stem cells for modelling Parkinson&#x2019;s Disease. J. Neurosci. Methods. 2020;340 doi: 10.1016/j.jneumeth.2020.108741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2020.108741</ArticleId><ArticleId IdType="pubmed">32311374</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 1976;73:5. doi: 10.1073/pnas.73.7.2424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.73.7.2424</ArticleId><ArticleId IdType="pmc">PMC430592</ArticleId><ArticleId IdType="pubmed">1065897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiatrak B., Kubis-Kubiak A., Piwowar A., Barg E. PC12 Cell Line: Cell Types, Coating of Culture Vessels, Differentiation and Other Culture Conditions. Cells. 2020;9:958. doi: 10.3390/cells9040958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040958</ArticleId><ArticleId IdType="pmc">PMC7227003</ArticleId><ArticleId IdType="pubmed">32295099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z., Xu J., Zheng W. Artemisinin protects PC12 cells against &#x3b2;-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox Biol. 2017;12:9. doi: 10.1016/j.redox.2017.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2017.04.003</ArticleId><ArticleId IdType="pmc">PMC5385605</ArticleId><ArticleId IdType="pubmed">28391183</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Benmohamed R., Arvanites A.C., Morimoto R.I., Ferrante R.J., Kirsch N.R., Silverman R.B. Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells. Bioorg. Med. Chem. 2011;20:17. doi: 10.1016/j.bmc.2011.11.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2011.11.039</ArticleId><ArticleId IdType="pmc">PMC3259267</ArticleId><ArticleId IdType="pubmed">22189273</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna A., Biryukov M., Trefois C., A Antony P.M., Hussong R., Lin J., Hein&#xe4;niemi M., Glusman G., Koeglsberger S., Boyd O., et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson&#x2019;s disease. BMC Genom. 2014;15:1154. doi: 10.1186/1471-2164-15-1154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-15-1154</ArticleId><ArticleId IdType="pmc">PMC4367834</ArticleId><ArticleId IdType="pubmed">25528190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotharius J., Falsig J., Van Beek J., Payne S., Dringen R., Brundin P., Leist M. Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway. J. Neurosci. 2005;25:6329&#x2013;6342. doi: 10.1523/JNEUROSCI.1746-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1746-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725277</ArticleId><ArticleId IdType="pubmed">16000623</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz D., P&#xf6;ltl D., Genewsky A., Weng M., Waldmann T., Schildknecht S., Leist M. Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J. Neurochem. 2011;119:15. doi: 10.1111/j.1471-4159.2011.07255.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07255.x</ArticleId><ArticleId IdType="pubmed">21434924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruben H. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat. Biotechnol. 2002;20:7. doi: 10.1038/nbt0702-675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt0702-675</ArticleId><ArticleId IdType="pubmed">12089551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes I.R., Russo F.B., Pignatari G.C., Evangelinellis M.M., Tavolari S., Muotri A.R., Beltr&#xe3;o-Braga P.C.B. Fibroblast sources: Where can we get them? Cytotechnology. 2016;68:6. doi: 10.1007/s10616-014-9771-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10616-014-9771-7</ArticleId><ArticleId IdType="pmc">PMC4754245</ArticleId><ArticleId IdType="pubmed">25060709</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein S., Moerman E.J., Soeldner J.S., Gleason R.E., Barnett D.M. Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science. 1978;199:2. doi: 10.1126/science.622567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.622567</ArticleId><ArticleId IdType="pubmed">622567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornsby P.J. Cellular Senescence and Tissue Aging In Vivo. J. Gerontol. Ser. A. 2002;57:6. doi: 10.1093/gerona/57.7.B251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/57.7.B251</ArticleId><ArticleId IdType="pubmed">12084795</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttenlocher A., Lakonishok M., Kinder M., Wu S., Truong T., Knudsen K.A., Horwitz A.F. Integrin and Cadherin Synergy Regulates Contact Inhibition of Migration and Motile Activity. J. Cell Biol. 1998;141:12. doi: 10.1083/jcb.141.2.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.141.2.515</ArticleId><ArticleId IdType="pmc">PMC2148455</ArticleId><ArticleId IdType="pubmed">9548728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary N., Nguyet T., Nguyen Q., Maguire A., Wynne C., Meade A.D. Comparison of sample preparation methodologies towards optimisation of Raman spectroscopy for peripheral blood mononuclear cells. Anal. Methods. 2021;13:14. doi: 10.1039/D0AY02040K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0AY02040K</ArticleId><ArticleId IdType="pubmed">33538723</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Annesley S.J., Allan C.Y., Sanislav O., Lidbury B.A., Lewis D.P., Fisher P.R. An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients. Int. J. Mol. Sci. 2020;21:1074. doi: 10.3390/ijms21031074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoepken H.H., Gispert S., Azizov M., Klinkenberg M., Ricciardi F., Kurz A., Morales-Gordo B., Bonin M., Riess O., Gasser T., et al. Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp. Neurol. 2008;212:7. doi: 10.1016/j.expneurol.2008.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2008.04.004</ArticleId><ArticleId IdType="pubmed">18511044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., et al. Classification and prediction of clinical Alzheimer&#x2019;s diagnosis based on plasma signaling proteins. Nat. Med. 2007;13:1359&#x2013;1362. doi: 10.1038/nm1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1653</ArticleId><ArticleId IdType="pubmed">17934472</ArticleId></ArticleIdList></Reference><Reference><Citation>Percy M.E., Andrews D., Potter H. Peripheral Markers of Alzheimer&#x2019;s Disease, Directions From the Alzheimer Pathogenic Pathway. Human Press; Totowa, NJ, USA: 2000.</Citation></Reference><Reference><Citation>Raffaele S., Boccazzi M., Fumagalli M. Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives. Cells. 2021;10:565. doi: 10.3390/cells10030565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030565</ArticleId><ArticleId IdType="pmc">PMC8000560</ArticleId><ArticleId IdType="pubmed">33807572</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards G., III, Gamez N., Armijo E., Kramm C., Morales R., Taylor-Presse K., Schulz P.E., Soto C., Moreno-Gonzalez I. Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson&#x2019;s Disease-Associated Pathology. Cells. 2019;8:1359. doi: 10.3390/cells8111359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8111359</ArticleId><ArticleId IdType="pmc">PMC6912680</ArticleId><ArticleId IdType="pubmed">31671704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K., Tanji K., Odagiri S., Miki Y., Mori F., Takahashi H. The Lewy body in Parkinson&#x2019;s disease and related neurodegenerative disorders. Mol. Neurobiol. 2013;47:495&#x2013;508. doi: 10.1007/s12035-012-8280-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8280-y</ArticleId><ArticleId IdType="pubmed">22622968</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., David B.T., Trawczynski M., Fessler R.G. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Stem Cell Rev. Rep. 2020;16:30. doi: 10.1007/s12015-019-09935-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09935-x</ArticleId><ArticleId IdType="pmc">PMC6987053</ArticleId><ArticleId IdType="pubmed">31760627</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki R., Hoki Y., Suga T., Obara C., Sunayama M., Imadome K., Fujita M., Kamimura S., Nakamura M., Wakayama S., et al. Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency. Nat. Commun. 2020;11:197. doi: 10.1038/s41467-019-13830-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13830-x</ArticleId><ArticleId IdType="pmc">PMC6954237</ArticleId><ArticleId IdType="pubmed">31924765</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevallos R.R., Edwards Y.J.K., Parant J.M., Yoder B.K., Hu K. Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs. Sci. Rep. 2020;10:19710. doi: 10.1038/s41598-020-76705-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76705-y</ArticleId><ArticleId IdType="pmc">PMC7661723</ArticleId><ArticleId IdType="pubmed">33184372</ArticleId></ArticleIdList></Reference><Reference><Citation>Houldcroft C.J., Petrova V., Liu J.Z., Frampton D., Anderson C.A., Gall A., Kellam P. Host Genetic Variants and Gene Expression Patterns Associated with Epstein-Barr Virus Copy Number in Lymphoblastoid Cell Lines. PLoS ONE. 2014;9:e108384. doi: 10.1371/journal.pone.0108384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108384</ArticleId><ArticleId IdType="pmc">PMC4188571</ArticleId><ArticleId IdType="pubmed">25290448</ArticleId></ArticleIdList></Reference><Reference><Citation>Longnecker R.M., Kieff E., Cohen J.I. Epstein-Barr Virus. 6th ed. Lippincott, Wilkins, and Williams; Philadelphia, PA, USA: 2013.</Citation></Reference><Reference><Citation>Hussain T., Mulherkar R. Lymphoblastoid Cell lines: A Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair. Int. J. Mol. Cell. Med. 2012;1:75&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920499</ArticleId><ArticleId IdType="pubmed">24551762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohyuddin A., Ayub Q., Siddiqi S., Carvalho-Silva D.R., Mazhar K., Rehman S., Firasat S., Dar A., Tyler-Smith C., Mehdi S.Q. Genetic instability in EBV-transformed lymphoblastoid cell lines. Biochim. Biophys. Acta-Gen. Subj. 2004;1670:3. doi: 10.1016/j.bbagen.2003.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2003.10.014</ArticleId><ArticleId IdType="pubmed">14729144</ArticleId></ArticleIdList></Reference><Reference><Citation>Caliskan M., Cusanocivh D., Ober C., Gilad Y. The effects of EBV transformation on gene expression levels and methylation profiles. Hum. Mol. Genet. 2011;21:1643&#x2013;1652. doi: 10.1093/hmg/ddr041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr041</ArticleId><ArticleId IdType="pmc">PMC3063990</ArticleId><ArticleId IdType="pubmed">21289059</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Sanislav O., Allan C.Y., Smith P.K., Annesley S.J., Fisher P.R. Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts. Int. J. Mol. Sci. 2021;22:2046. doi: 10.3390/ijms22042046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042046</ArticleId><ArticleId IdType="pmc">PMC7921983</ArticleId><ArticleId IdType="pubmed">33669532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E., Kleffmann T., Edgar C., de Lange M., Vallings R., Tate W. SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J. Transl. Med. 2020;18:1&#x2013;18. doi: 10.1186/s12967-020-02533-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio B., Annoni G., Vergani C., Solano D.C., Racchi M., Govoni S. Fibroblasts from Alzheimer&#x2019;s disease donors do not differ from controls in response to heat shock. Neurosci. Lett. 1998;256:4. doi: 10.1016/S0304-3940(98)00741-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(98)00741-1</ArticleId><ArticleId IdType="pubmed">9832208</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales-Reynoso M.A., Ochoa-Hern&#xe1;ndez A.B., Ju&#xe1;rez-V&#xe1;zquez C.I., Barros-N&#xfa;&#xf1;ez P. Epigenetic mechanisms in the development of memory and their involvement in certain neurological diseases. Neurology. 2016;31:11. doi: 10.1016/j.nrleng.2014.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrleng.2014.02.011</ArticleId><ArticleId IdType="pubmed">25217064</ArticleId></ArticleIdList></Reference><Reference><Citation>Loke Y.J., Hannan A.J., Craig J.M. The Role of Epigenetic Change in Autism Spectrum Disorders. Front. Neurol. 2015;6 doi: 10.3389/fneur.2015.00107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2015.00107</ArticleId><ArticleId IdType="pmc">PMC4443738</ArticleId><ArticleId IdType="pubmed">26074864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sie L., Loong S., Tan E.K. Utility of lymphoblastoid cell lines. J. Neurosci. Res. 2009;87:1953&#x2013;1959. doi: 10.1002/jnr.22000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22000</ArticleId><ArticleId IdType="pubmed">19224581</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Dominic J., Double K.L. Oxidative stress in the aging substantia nigra and the etiology of Parkinson&#x2019;s disease. Aging Cell. 2019;18:e13031. doi: 10.1111/acel.13031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13031</ArticleId><ArticleId IdType="pmc">PMC6826160</ArticleId><ArticleId IdType="pubmed">31432604</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidyadhara D.J., Lee J.E., Chandra S.S. Role of the endolysosomal system in Parkinson&#x2019;s disease. J. Neurochem. 2019;150:487&#x2013;506. doi: 10.1111/jnc.14820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14820</ArticleId><ArticleId IdType="pmc">PMC6707858</ArticleId><ArticleId IdType="pubmed">31287913</ArticleId></ArticleIdList></Reference><Reference><Citation>Alston C.L., Rocha M.C., Lax N.Z., Turnbull D.M., Taylor R.W. The genetics and pathology of mitochondrial disease. J. Pathol. 2017;241:236&#x2013;250. doi: 10.1002/path.4809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4809</ArticleId><ArticleId IdType="pmc">PMC5215404</ArticleId><ArticleId IdType="pubmed">27659608</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson&#x2019;s disease. Nat. Neurosci. 2000;3:6. doi: 10.1038/81834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/81834</ArticleId><ArticleId IdType="pubmed">11100151</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiruchelvam M., Richfield E.K., Baggs R.B., Tank A.W., Cory-Slechta D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson&#x2019;s disease. J. Neurosci. 2000;20:9207&#x2013;9214. doi: 10.1523/JNEUROSCI.20-24-09207.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-24-09207.2000</ArticleId><ArticleId IdType="pmc">PMC6773035</ArticleId><ArticleId IdType="pubmed">11124998</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauer W., Przedborski S. Parkinson&#x2019;s Disease: Mechanisms and Models. Neuron. 2003;39:889&#x2013;909. doi: 10.1016/S0896-6273(03)00568-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00568-3</ArticleId><ArticleId IdType="pubmed">12971891</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacelli C., Gigu&#xe8;re N., Bourque M.J., L&#xe9;vesque M., Slack R.S., Trudeau L.&#xc9;. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Curr. Biol. 2015;25:12. doi: 10.1016/j.cub.2015.07.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.07.050</ArticleId><ArticleId IdType="pubmed">26320949</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesley S.J., Lay S.T., De Piazza S.W., Sanislav O., Hammersley E., Allan C.Y., Francione L.M., Bui M.Q., Chen Z.P., Ngoei K.R., et al. Immortalized Parkinson&#x2019;s disease lymphocytes have enhanced mitochondrial respiratory activity. Dis. Models Mech. 2016;9:1295&#x2013;1305. doi: 10.1242/dmm.025684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.025684</ArticleId><ArticleId IdType="pmc">PMC5117226</ArticleId><ArticleId IdType="pubmed">27638668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugalde C.L., Annesley S.J., Gordon S.E., Mroczek K., Perugini M.A., Lawson V.A., Fisher P.R., Finkelstein D.I., Hill A.F. Misfolded alpha-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells. Dis. Models Mech. 2020;13:dmm040899. doi: 10.1242/dmm.040899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.040899</ArticleId><ArticleId IdType="pmc">PMC6994945</ArticleId><ArticleId IdType="pubmed">31848207</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando S., Allan C.Y., Mroczek K., Pearce X., Sanislav O., Fisher P.R., Annesley S.J. Cytotoxicity and Mitochondrial Dysregulation Caused by &#x3b1;-Synuclein in Dictyostelium discoideum. Cells. 2020;9:2289. doi: 10.3390/cells9102289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102289</ArticleId><ArticleId IdType="pmc">PMC7602147</ArticleId><ArticleId IdType="pubmed">33066427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Annesley S.J., Jasim R.A.F., Musco V.J., Sanislav O., Fisher P.R. The Parkinson&#x2019;s disease-associated protein DJ-1 plays a positive nonmitochondrial role in endocytosis in Dictyostelium cells. Dis. Models Mech. 2017;10:1261&#x2013;1271. doi: 10.1242/dmm.028084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.028084</ArticleId><ArticleId IdType="pmc">PMC5665451</ArticleId><ArticleId IdType="pubmed">28819044</ArticleId></ArticleIdList></Reference><Reference><Citation>Haylett W.S.C., van der Westhuizen F., van Dyk H., van der Merwe L., van der Merwe C., Loos B., Carr J., Kinnear C., Bardien S. Altered Mitochondrial Respiration and Other Features of Mitochondrial Function in Parkin-Mutant Fibroblasts from Parkinson&#x2019;s Disease Patients. Parkinsons Dis. 2016 doi: 10.1155/2016/1819209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/1819209</ArticleId><ArticleId IdType="pmc">PMC4807059</ArticleId><ArticleId IdType="pubmed">27034887</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi S., Cox M., Lugon M., Hodkinson M., Tomkins A. Increased energy expenditure in Parkinson&#x2019;s disease. BMJ. 1990;301:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1664392</ArticleId><ArticleId IdType="pubmed">2271826</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C.W.A. Genetics of Parkinson&#x2019;s disease. Cold Spring Harb. Perspect. Med. 2012;2 doi: 10.1101/cshperspect.a008888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a008888</ArticleId><ArticleId IdType="pmc">PMC3253033</ArticleId><ArticleId IdType="pubmed">22315721</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hunt C.P., Toste C.M., Boularand S., Deprets S., Dubois L., Sanders L.H. Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson&#x2019;s disease. Sci. Rep. 2020;10:17293. doi: 10.1038/s41598-020-74195-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74195-6</ArticleId><ArticleId IdType="pmc">PMC7557909</ArticleId><ArticleId IdType="pubmed">33057100</ArticleId></ArticleIdList></Reference><Reference><Citation>Howlett E.H.J.N., Belmonte F., Zafar F., Hu X., Kluss J., Sch&#xfc;le B., Kaufman B.A., Greenamyre J.T., Sanders L.H. LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson&#x2019;s disease. Hum. Mol. Genet. 2017;26:12. doi: 10.1093/hmg/ddx320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx320</ArticleId><ArticleId IdType="pmc">PMC5886254</ArticleId><ArticleId IdType="pubmed">28973664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia S.J., Tan E.-K., Chao Y.X.I. Historical Perspective: Models of Parkinson&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:2464. doi: 10.3390/ijms21072464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072464</ArticleId><ArticleId IdType="pmc">PMC7177377</ArticleId><ArticleId IdType="pubmed">32252301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel H.A., Overk C.R., Oueslati A., Masliah E. The many faces of &#x3b1;-synuclein: From structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 2013;14:11. doi: 10.1038/nrn3406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3406</ArticleId><ArticleId IdType="pmc">PMC4295774</ArticleId><ArticleId IdType="pubmed">23254192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R., Chen S.W., Bigi A., Camino J.D., Xu C.K., Dobson C.M., Chiti F., Cremades N., Cecchi C. The release of toxic oligomers from &#x3b1;-synuclein fibrils induces dysfunction in neuronal cells. Nat. Commun. 2021;12:1814. doi: 10.1038/s41467-021-21937-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21937-3</ArticleId><ArticleId IdType="pmc">PMC7985515</ArticleId><ArticleId IdType="pubmed">33753734</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitieri F.F.A., Cannella M., Orobello S., Fulceri F., Lenzi P., Fornai F. Abnormal morphology of peripheral cell tissues from patients with Huntington disease. Abnormal morphology of peripheral cell tissues from patients with Huntington disease. J. Neural Transm. 2010;117:7. doi: 10.1007/s00702-009-0328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-009-0328-4</ArticleId><ArticleId IdType="pubmed">19834779</ArticleId></ArticleIdList></Reference><Reference><Citation>Naia L.F.I., Cunha-Oliveira T., Duarte A.I., Ribeiro M., Rosenstock T.R., La&#xe7;o M.N., Ribeiro M.J., Oliveira C.R., Saudou F., Humbert S., et al. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington&#x2019;s Disease human lymphoblasts. Mol. Neurobiol. 2015;51:18. doi: 10.1007/s12035-014-8735-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8735-4</ArticleId><ArticleId IdType="pubmed">24841383</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuade L.R.B.A., Scott H.A., Khaira S., Baker M.S., Schmidt U. Proteomics of Huntington&#x2019;s disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances. J. Proteome Res. 2014;13:12. doi: 10.1021/pr500649m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr500649m</ArticleId><ArticleId IdType="pubmed">25316320</ArticleId></ArticleIdList></Reference><Reference><Citation>Panov A.V., Gutekunst C.-A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., Greenamyre J.T. Early mitochondrial calcium defects in Huntington&#x2019;s disease are a direct effect of polyglutamines. Nat. Neurosci. 2002;5:6. doi: 10.1038/nn884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn884</ArticleId><ArticleId IdType="pubmed">12089530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia E.M., Chau S., Sparagna G.C., Sipione S., Hatch G.M. Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly. Lipids. 2016;51:9. doi: 10.1007/s11745-015-4110-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-015-4110-0</ArticleId><ArticleId IdType="pubmed">26846325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae B.I., Xu H., Igarashi S., Fujimuro M., Agrawal N., Taya Y., Hayward S.D., Moran T.H., Montell C., Ross C.A., et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington&#x2019;s disease. Neuron. 2005;47:13. doi: 10.1016/j.neuron.2005.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.06.005</ArticleId><ArticleId IdType="pubmed">15996546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawa A., Wiegand G.W., Cooper J., Margolis R.L., Sharp A.H., Lawler J.F., Jr., Greenamyre J.T., Snyder S.H., Ross C.A. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med. 1999;5:5. doi: 10.1038/13518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/13518</ArticleId><ArticleId IdType="pubmed">10502825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mormone E., Matarrese P., Tinari A., Cannella M., Maglione V., Farrace M.G., Piacentini M., Frati L., Malorni W., Squitieri F. Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington&#x2019;s disease. J. Neurochem. 2006;98:10. doi: 10.1111/j.1471-4159.2006.03998.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03998.x</ArticleId><ArticleId IdType="pubmed">16895579</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglione V.C.M., Gradini R., Cislaghi G., Squitieri F. Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington&#x2019;s disease mutation. Mech. Ageing Dev. 2006;127:4. doi: 10.1016/j.mad.2005.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2005.09.011</ArticleId><ArticleId IdType="pubmed">16289252</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:17. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Bordoni M., Drufuca L., Diamanti L., Sproviero D., Trotti R., Bernuzzi S., La Salvia S., Gagliardi S., Ceroni M., et al. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis. Models Mech. 2018;11 doi: 10.1242/dmm.031625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.031625</ArticleId><ArticleId IdType="pmc">PMC5897724</ArticleId><ArticleId IdType="pubmed">29419416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Brown R.H., Jr. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D.A., Trotti D., Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA. 2012;109:6. doi: 10.1073/pnas.1115402109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M.D., Trounce I.A., Jun A.S., Allen J.C., Wallace D.C. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber&#x2019;s hereditary optic neuropathy mitochondrial DNA mutation. J. Biol. Chem. 2000;275:6. doi: 10.1074/jbc.M006476200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M006476200</ArticleId><ArticleId IdType="pubmed">10976107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri M., Brajkovic S., Riboldi G., Ronchi D., Rizzo F., Bresolin N., Corti S., Comi G.P. Mitochondrial Fusion Proteins and Human Diseases. Neurol. Res. Int. 2013 doi: 10.1155/2013/293893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/293893</ArticleId><ArticleId IdType="pmc">PMC3678461</ArticleId><ArticleId IdType="pubmed">23781337</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheffield V.C., Stone E.M., Alward W.L., Drack A.V., Johnson A.T., Streb L.M., Nichols B.E. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat. Genet. 1993;4:4. doi: 10.1038/ng0593-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0593-47</ArticleId><ArticleId IdType="pubmed">8513321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., H&#xe9;on E., Krupin T., Ritch R., Kreutzer D., et al. Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin. Science. 2002;295:3. doi: 10.1126/science.1066901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1066901</ArticleId><ArticleId IdType="pubmed">11834836</ArticleId></ArticleIdList></Reference><Reference><Citation>Fingert J.H. Primary open-angle glaucoma genes. Eye. 2011;25:9. doi: 10.1038/eye.2011.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2011.97</ArticleId><ArticleId IdType="pmc">PMC3171270</ArticleId><ArticleId IdType="pubmed">21562585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Sheck L., Crowston J.G., Van Bergen N.J., O&#x2019;Neill E.C., O&#x2019;Hare F., Xiang Y., Kong G., Chrysostomou V., Vincent A.L., et al. Impaired Complex-I-Linked Respiration and ATP Synthesis in Primary Open-Angle Glaucoma Patient Lymphoblasts. Invest. Ophthalmol. Vis. Sci. 2012;53:7. doi: 10.1167/iovs.12-9596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.12-9596</ArticleId><ArticleId IdType="pubmed">22427588</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Bergen N.J., Crowston J.G., Kearns L.S., Staffieri S.E., Hewitt A.W., Cohn A.C., Mackey D.A., Trounce I.A. Mitochondrial Oxidative Phosphorylation Compensation May Preserve Vision in Patients with OPA1-Linked Autosomal Dominant Optic Atrophy. PLoS ONE. 2011;6:e21347. doi: 10.1371/journal.pone.0021347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021347</ArticleId><ArticleId IdType="pmc">PMC3120866</ArticleId><ArticleId IdType="pubmed">21731710</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Bergen N.J., Crowston J.G., Craig J.E., Burdon K.P., Kearns L.S., Sharma S., Hewitt A.W., Mackey D.A., Trounce I.A. Measurement of Systemic Mitochondrial Function in Advanced Primary Open-Angle Glaucoma and Leber Hereditary Optic Neuropathy. PLoS ONE. 2015;10:e0140919. doi: 10.1371/journal.pone.0140919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140919</ArticleId><ArticleId IdType="pmc">PMC4619697</ArticleId><ArticleId IdType="pubmed">26496696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez M.I.G.L., Van Bergen N.J., Kearns L.S., Ziemann M., Liang H., Hewitt A.W., Mackey D.A., Trounce I.A. OXPHOS bioenergetic compensation does not explain disease penetrance in Leber hereditary optic neuropathy. Mitochondrion. 2020;54:9. doi: 10.1016/j.mito.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2020.07.003</ArticleId><ArticleId IdType="pubmed">32687992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagerman R.J.L., Heinrichs M.W., Tassone F., Wilson R., Hills J., Grigsby J., Gage B., Hagerman P.J. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:4. doi: 10.1212/WNL.57.1.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.1.127</ArticleId><ArticleId IdType="pubmed">11445641</ArticleId></ArticleIdList></Reference><Reference><Citation>Loesch D.Z., Tassone F., Mellick G.D., Horne M., Rubio J.P., Bui M.Q., Francis D., Storey E. Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females. Mov. Disord. 2018;33:4. doi: 10.1002/mds.27420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27420</ArticleId><ArticleId IdType="pmc">PMC6116531</ArticleId><ArticleId IdType="pubmed">30153395</ArticleId></ArticleIdList></Reference><Reference><Citation>Loesch D.Z., Khaniani M.S., Slater H.R., Rubio J.P., Bui Q.M., Kotschet K., D&#x2019;Souza W., Venn A., Kalitsis P., Choo A.K.H., et al. Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism. Clin. Genet. 2009;76:6. doi: 10.1111/j.1399-0004.2009.01275.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2009.01275.x</ArticleId><ArticleId IdType="pmc">PMC2888465</ArticleId><ArticleId IdType="pubmed">19796183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall D.A., Nag S., Ouyang B., Bennett D.A., Liu Y., Ali A., Zhou L., Berry-Kravis E. Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death. Mov. Disord. 2020;35:9. doi: 10.1002/mds.28086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28086</ArticleId><ArticleId IdType="pmc">PMC10335806</ArticleId><ArticleId IdType="pubmed">32463542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenneson A.Z.F., Hagedorn C.H., Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 2001;10:6. doi: 10.1093/hmg/10.14.1449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.14.1449</ArticleId><ArticleId IdType="pubmed">11448936</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd P.K., Krans A., Pandey U.B., Di Prospero N.A., Min K.T., Taylor J.P., Paulson H.L. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet. 2011;6:e1001240. doi: 10.1371/journal.pgen.1001240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001240</ArticleId><ArticleId IdType="pmc">PMC3000359</ArticleId><ArticleId IdType="pubmed">21170301</ArticleId></ArticleIdList></Reference><Reference><Citation>Loesch D.Z., Annesley S.J., Trost N., Bui M.Q., Lay S.T., Storey E., De Piazza S., Sanislav O., Francione L.M., Hammersley E.M., et al. Novel blood biomarkers are associated with the white matter lesion in Fragile X Associated Tremor/Ataxia Syndrome. Neurodegener. Dis. 2017;17:9. doi: 10.1159/000446803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446803</ArticleId><ArticleId IdType="pubmed">27602566</ArticleId></ArticleIdList></Reference><Reference><Citation>Loesch-Mdzewska D.Z., Trost N., Bui M.Q., Hammersley E., Lay S.T., Annesley S.J., Sanislav O., Allen C.Y., Tassone F., Chen Z.-P., et al. The Spectrum of Neurological, Cognitive and White Matter Changes and Premutation Status Categories of Older Male Carriers of the FMR1 Alleles are Linked to Genetic (CGG and FMR mRNA) and Cellular Stress (AMPK) Markers. Front. Genet. 2018;9:531. doi: 10.3389/fgene.2018.00531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00531</ArticleId><ArticleId IdType="pmc">PMC6241173</ArticleId><ArticleId IdType="pubmed">30483310</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallings R. Chronic Fatigue Syndrome M.E. Symptoms: Diagnosis &amp; Management. Calico Publishing Ltd.; Auckland, New Zealand: 2012.</Citation></Reference><Reference><Citation>Tomas C.B., Strassheim V., Elson J.L., Newton J., Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE. 2017;12:e0186802. doi: 10.1371/journal.pone.0186802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C.B., Newton J.L., Elson J.L. Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types. PeerJ. 2019;7:e6500. doi: 10.7717/peerj.6500.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.6500</ArticleId><ArticleId IdType="pmc">PMC6398432</ArticleId><ArticleId IdType="pubmed">30847260</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits B., van den Heuvel L., Knoop H., Kusters B., Janssen A., Borm G., Bleijenberg G., Rodenburg R., van Engelen B. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion. 2011;11:4. doi: 10.1016/j.mito.2011.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2011.05.005</ArticleId><ArticleId IdType="pubmed">21664495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciregia F., Kollipara L., Giusti L., Zahedi R.P., Giacomelli C., Mazzoni M.R., Giannaccini G., Scarpellini P., Urbani A., Sickmann A., et al. Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome. Transl. Psychiatry. 2016;6:e904. doi: 10.1038/tp.2016.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2016.184</ArticleId><ArticleId IdType="pmc">PMC5048217</ArticleId><ArticleId IdType="pubmed">27676445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik N., Fear D., Richards S.C., Mcdermott C.R., Nuwaysir E.F., Kellam P., Harrison T.J., Wilkinson R.J., Tyrrell D.A., Holgate S.T., et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J. Clin. Pathol. 2005;58:7. doi: 10.1136/jcp.2005.025718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2005.025718</ArticleId><ArticleId IdType="pmc">PMC1770875</ArticleId><ArticleId IdType="pubmed">16049284</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Sanislav O., Allan C.Y., Annesley S.J., Fisher P.R. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Int. J. Mol. Sci. 2020;21:1142. doi: 10.3390/ijms21031142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031142</ArticleId><ArticleId IdType="pmc">PMC7037777</ArticleId><ArticleId IdType="pubmed">32046336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>